Q1 2026 PAVmed Inc Earnings Call Transcript
Key Points
- PAVmed Inc (PAVM) has successfully completed the restructuring of its capital structure, resulting in a clean cap table consisting only of common stock and term debt.
- The company is well-positioned to operate as a high-growth, diversified commercial life sciences company with multiple independently financed subsidiaries.
- Lucid Diagnostics, a subsidiary of PAVmed Inc (PAVM), is on the cusp of transformative milestones, including impending Medicare coverage.
- Veris, another subsidiary, is progressing well with its commercial phase at Ohio State University, with positive feedback and successful EHR integration.
- PAVmed Inc (PAVM) has raised capital that extends its runway well into 2027, providing financial stability for future operations.
- There is frustration over the delay in obtaining Medicare coverage for Lucid Diagnostics, which has been dragging on longer than expected.
- The company has faced challenges in raising capital for early-stage technologies, particularly in the medical device incubator model.
- PAVmed Inc (PAVM) reported a GAAP net loss of $1.1 million for the quarter, driven by changes in the fair value of Lucid shares.
- Operating expenses have increased, with a first-quarter non-GAAP OpEx of $5.9 million, reflecting higher R&D expenditures and professional fees.
- The company is unlikely to expand its commercial footprint for Veris until additional capital is raised, limiting immediate growth opportunities.
Good morning, and welcome to the PAVmed's first quarter 2026 business update conference call. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference call over to Matt Riley, PAVmed's Vice President of Investor Relations. Please go ahead.
Thank you, operator, and good morning, everyone. Thank you for participating in today's business update call. Joining me today on the call are Dr. Lishan Aklog, Chairman and Chief Executive Officer of PAVmed; along with Dennis McGrath, Chief Financial Officer of PAVmed. The press release announcing our business update and financial results is available on PAVmed's website. Please take a moment to read the disclaimers about forward-looking statements in the press release.
The business update press release and conference call all include forward-looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
